Welcome to LookChem.com Sign In|Join Free

CAS

  • or

47846-88-8

Post Buying Request

47846-88-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

47846-88-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 47846-88-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,7,8,4 and 6 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 47846-88:
(7*4)+(6*7)+(5*8)+(4*4)+(3*6)+(2*8)+(1*8)=168
168 % 10 = 8
So 47846-88-8 is a valid CAS Registry Number.

47846-88-8Relevant articles and documents

Prodrug-inspired probes selective to cathepsin B over other cysteine cathepsins

Chowdhury, Morshed A.,Moya, Ignace A.,Bhilocha, Shardul,McMillan, Cody C.,Vigliarolo, Brady G.,Zehbe, Ingeborg,Phenix, Christopher P.

, p. 6092 - 6104 (2014/08/18)

Cathepsin B (CTB) is a cysteine protease believed to be an important therapeutic target or biomarker for several diseases including aggressive cancer, arthritis, and parasitic infections. The development of probes capable of assessing CTB activity in cell lysates, living cells, and animal models of disease are needed to understand its role in disease progression. However, discovering probes selective to cathepsin B over other cysteine cathepsins is a significant challenge due to overlap of preferred substrates and binding site homology in this family of proteases. Herein we report the synthesis and detailed evaluation of two prodrug-inspired fluorogenic peptides designed to be efficient and selective substrate-based probes for CTB. Through cell lysate and cell assays, a promising lead candidate was identified that is efficiently processed and has high specificity for CTB over other cysteine cathepsins. This work represents a key step toward the design of rapid release prodrugs or substrate-based molecular imaging probes specific to CTB.

SYNTHESIS OF A MODIFIED FRAGMENT 13-19 OF THE SEQUENCE OF ACTH USING SILYL PROTECTION

Karel'skii, V. N.,Krysin, E. P.,Rabinovich, A. K.,Antonov, A. A.,Smirnov, M. B.

, p. 282 - 286 (2007/10/02)

A new scheme for the synthesis of a peptide representing a modified analog of fragments 13-19 of the sequence of the adrenocorticotropic hormone has been described, which uses a number of stages the trimethylsilyl grouping for the protection of the carbox

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 47846-88-8